CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.

MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.

COLUMBUS, Ohio (WCMH) — A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...